Skip to content

A prospective, multicenter, randomized controlled trial of JieGuQiLi Capsule in the treatment of distal radius fracture

A prospective, multicenter, randomized controlled trial of JieGuQiLi Capsule in the treatment of distal radius fracture

Status
Active, not recruiting
Phases
Phase 4
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2300077662
Enrollment
Unknown
Registered
2023-11-15
Start date
2023-11-17
Completion date
Unknown
Last updated
2023-11-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Distal radius fracture

Interventions

Experimental group:Manual reduction + gypsum fixation + healthy education + JieGuQiLi Capsule
Control group:Manual reduction + gypsum fixation + healthy education + JieGuQiLi Capsule placebo

Sponsors

The First Affiliated Hospital of Hunan University of Traditional Chinese Medicine
Lead Sponsor

Eligibility

Sex/Gender
All
Age
45 Years to 75 Years

Inclusion criteria

Inclusion criteria: 1. According to the diagnostic criteria of distal radius fracture, blood stasis due to qi stagnation or blood stasis due to qi deficiency; 2. Meet the reset standard after manual reduction; 3. Both women and men, from 45 to 75 years old; 4. Injury to presentation less than 1 week and non-open fracture; 5. The patients sign informed consent voluntarily.

Exclusion criteria

Exclusion criteria: 1. Pathological fractures or old fractures; 2. Severe vascular, myochiral, or nerve injury or history of previous lesions and surgery in the wrist; 3. Patients with severe heart, liver, kidney and other organ insufficiency, blood system and autoimmune diseases, acute and chronic infections, malignant tumors, or severe mental disorders who cannot cooperate with treatment; 4. Allergy to the test drug; 5. Pregnant and lactating female patients.

Design outcomes

Primary

MeasureTime frame
Wrist pain score;

Secondary

MeasureTime frame
Wrist Gartland-Werley score;Degree of swelling;TCM syndrome;Fracture healing;Security indicators;

Countries

China

Contacts

Public ContactShaofeng Yang/ Liguo Zhu

The First Affiliated Hospital of Hunan University of Chinese Medicine/ Wangjing Hospital, China Academy of Chinese Medical Sciences

Zhlg95@aliyun.com+86 138 0103 2518

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026